KDventures AB's EBIT per Share for the
three
months ended in Mar. 2026 was $-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.01.
During the past 3 years, the average EBIT per Share Growth Rate was 14.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 12.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 20.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for KDventures AB's EBIT per Share or its related term are showing as below:
KDEVF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -125.1 Med: 23.1 Max: 51.1
Current: 14.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of KDventures AB was 51.10% per year. The lowest was -125.10% per year. And the median was 23.10% per year.
KDEVF's 3-Year EBIT Growth Rate is ranked worse than 51.74% of 1181
companies
in the Biotechnology industry
Industry Median: 15.5
vs KDEVF: 14.30
KDventures AB's EBIT for the
three
months ended in Mar. 2026 was $-0.58 Mil.
KDventures AB (OTCPK:KDEVF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
KDventures AB EBIT per Share Related Terms
KDventures AB EBIT per Share Historical Data
* Premium members only.
The historical data trend for KDventures AB's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDventures AB (KDEVF) has a EBIT per Share of $-0.01 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on KDventures AB and its competitors. According to the industry distribution chart, KDventures AB ranks #611 out of 1181 companies in the Biotechnology industry, placing it in the top 51.7%.
Is KDventures AB's EBIT per Share too high?
KDventures AB's current EBIT per Share is $-0.01. Based on the distribution chart, KDventures AB ranks #611 out of 1181 companies in the Biotechnology industry, which is below the industry midpoint. Overall, KDventures AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, KDventures AB ranks #611 out of 1181 companies for EBIT per Share. This places KDventures AB in the lower half of its industry. The industry median EBIT per Share is 15.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.50, based on 1,181 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on KDventures AB and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KDventures AB's current EBIT per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
KDventures AB (KDEVF) has a current EBIT per Share of $-0.01. The stock's GF Value™ is $0.67, compared to a current price of $0.26 — trading 61.6% below its estimated fair value. The current EBIT per Share is $-0.01. KDventures AB's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For KDventures AB (KDEVF), the current EBIT per Share is $-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KDventures AB (KDEVF) Overvalued in 2026?
Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued.
The current stock price of $0.26 is trading 61.6% below its estimated GF Value™ of $0.67.
Key valuation signals for KDEVF:
EBIT per Share: $-0.01
GF Value™: $0.67 vs. price of $0.26 (61.6% below fair value)
No single metric tells the full story. See the KDEVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
30GF Score
Get the complete analysis for KDEVF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KDEVF has been successfully added to your 
